ClinicalResearch IO

Clinical Research IO (CRIO) offers a range of clinical trial software, including a 1) clinical trial management system to manage patient recruitment, visits, and finances, 2) e-source platform to manage the collection and storage of patient data such as lab reports, examination notes, and self-reported surveys, and 3) e-regulatory platform to manage documentation of regulatory required documents and e-signatures.

These tools allow researchers to enter and review data electronically, along with enabling patients to monitor and provide consent through the system. Additionally, the system can organize workflow tasks such as payments and reimbursements, manage patient recruitment, and schedule patient visits. Furthermore, the system is compliant with industry standards including HIPAA, GDPR, FDA 21 CFR Part 11, and GCP.

Key customers and partnerships

As of May 2024, the company’s system had been adopted by 2,000+ clinical research sites across 25+ geographies. This growth was enabled by CRIO being the first company to achieve mass commercialization of an electronic sourcing system for clinical trials (initially launched in September 2016). The company’s customer base includes companies like Regeneris Medical, Optimed Research, and Medex Healthcare.

Funding and financials

In May 2024, the company raised an undisclosed sum in an equity funding round led by global private equity firm, The Riverside Company. The funding is earmarked for scaling up CRIO's capabilities and driving product enhancement and global expansion. The company also noted that the funding was expected to enhance its customer support operations.